← Back to patent-cliff list
CAS 1619267-22-9
2-(2-chloro-5-nitrophenyl)pyridine 1-oxide
Codes: VISM-007
Application context (from source-drug indications)
Basal cell carcinomaVismodegibMultiple myelomaVismodegibLymphomaVismodegibSolid tumourVismodegibHaematological malignancyVismodegibMesenchymal chondrosarcomaVismodegib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Vismodegib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-bromo-1-chloro-4-nitrobenzene→4-chloro-3-(pyridin-2-yl)aniline→pyridine 1-oxide→2-(2-chloro-5-nitrophenyl)pyridine 1-oxide→2-chloro-4-(methylsulfonyl)benzoic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.